Leukotriene C4 synthase promoter polymorphism in aspirin - induced asthma.
- Author:
Jae Youn CHO
;
Sang Yeub LEE
;
Seon Ae HAN
;
Se Hwa YOO
;
Sun Sin KIM
;
Hae Sim PARK
;
Jung Won PARK
;
Chein Soo HONG
;
Kwang Ho IN
- Publication Type:Original Article
- Keywords:
LTC4 synthase;
polymorphism;
aspirin induced asthma
- MeSH:
Aspirin*;
Asthma*;
Asthma, Aspirin-Induced;
Genotype;
Humans;
Leukotriene C4*;
Mucous Membrane;
Polymerase Chain Reaction;
Polymorphism, Genetic;
Polymorphism, Restriction Fragment Length
- From:Journal of Asthma, Allergy and Clinical Immunology
1999;19(4):542-547
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Aspirin/NSAIDs can release cysteinyl-leukotriene (cys-LTs) into airways and precipitate asthmatic symptoms in aspirin - induced asthma(AIA). It has been reported that there is profound overexpression of LTC4 synthase in their bronchial mucosa, compared to aspirin-tolerant asthma. Objective : We observed whether genetic polymorphism of LTC4 synthase may be predisposed to LTC4 synthase overexpression in AIA. Subject and METHOD: Forty - four AIA patients having positive responses on lysin aspirin bron choprovocation tests and 47 non - aspirin induced asthma ( non - AIA ) patients having negative challenges and 32 healthy controls were enrolled. The genotypes of the promoter LTC4 synthase gene ( A,C transversion ) were determined by polymerase chain reaction and restriction fragment length polymorphism ( RFLP ) method. RESULTS: LTC4 synthase promoter polymorphism ( A444C btransversion) was not significantly different between non - AIA and AIA patients (p>0.05). Conclusion These findings suggest that genetic polymorphism of LTC4 synthase promoter may not be predisposed to LTC, synthase overexpression in AIA.
